Neuronetics, Inc..
American company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
One to three months ago
-
Neuronetics, Inc. operates Greenbrook treatment centers across the US and Keith Sullivan serves as its President and CEO.Some support2 reports1 development inside
-
Cory Anderson was promoted to EVP/GM of Greenbrook clinics, and Rob Greene was appointed Senior VP of Sales at Neuronetics, Inc.Some support1 report
Gone quiet
No new reports in 90+ days-
Steven Pfanstiel was appointed as the new Chief Financial Officer of Neuronetics, Inc., replacing Steve Furlong.Some support1 report
-
Neuronetics, Inc. reported that its revenue forecast growth exceeded the industry average.Some support1 report
-
TMS manufacturer Neuronetics gained FDA clearance for its NeuroStar system for use in adolescents.Some support4 reports
No events began in the chosen period. Widen it, or reset.
Around Neuronetics, Inc. this week
News at the entities that move Neuronetics, Inc. most-
TMS StructuralThe Labour Party and TMS entered a formal alliance to support Bola Ahmed Tinubu's economic and structural reforms.Moves Neuronetics, Inc.
-
FDA StructuralThe FDA requested additional clinical data from Unicycive Therapeutics.Moves Neuronetics, Inc.
-
Royal Bank of Canada StructuralRoyal Bank of Canada dropped its price objective for Crown Castle Inc., while Citigroup reiterated an outperform rating.Moves Neuronetics, Inc.
-
SEC StructuralFranklin Templeton filed with the SEC to launch new ETFs seeking to integrate Bitcoin into its product offerings.Moves Neuronetics, Inc.
Connections
The 8 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Cory Anderson Structural
Cory Anderson serves as a senior executive (CTO) at Neuronetics, Inc.
-
Keith Sullivan Structural
Keith Sullivan serves as the President and CEO of Neuronetics, Inc.
-
TMS Structural
Neuronetics utilizes TMS technology as the core system for developing and marketing its mental health treatments.
-
Royal Bank of Canada Structural
Royal Bank of Canada increased its financial stake in Neuronetics, establishing an ownership relationship.
-
Rob Greene Structural
Rob Greene holds the position of Senior VP of Sales at Neuronetics, Inc.
-
FDA Structural
The FDA grants regulatory clearance for Neuronetics' NeuroStar product.
-
SEC Structural
Neuronetics operates under SEC rules requiring major shareholders to disclose trades with the commission.
-
Rockville Shared context
Neuronetics established a presence in Rockville by opening a National Center of Excellence.
History
Events by the month they beganAugust 2026
1 eventJune 2026
4 events- Neuronetics, Inc. operates Greenbrook treatment centers across the US and Keith Sullivan serves as its President and CEO.
- Steven Pfanstiel was appointed as the new Chief Financial Officer of Neuronetics, Inc., replacing Steve Furlong.
- Neuronetics, Inc. reported that its revenue forecast growth exceeded the industry average.
- TMS manufacturer Neuronetics gained FDA clearance for its NeuroStar system for use in adolescents.